TY - JOUR
T1 - The dASPP-dRASSF8 complex regulates cell-cell adhesion during Drosophila retinal morphogenesis
AU - Langton, Paul F
AU - Colombani, Julien
AU - Chan, Eunice H Y
AU - Wepf, Alexander
AU - Gstaiger, Matthias
AU - Tapon, Nicolas
PY - 2009/12/15
Y1 - 2009/12/15
N2 - BACKGROUND: Adherens junctions (AJs) provide structure to epithelial tissues by connecting adjacent cells through homophilic E-cadherin interactions and are linked to the actin cytoskeleton via the intermediate binding proteins beta-catenin and alpha-catenin. Rather than being static structures, AJs are extensively remodeled during development, allowing the cell rearrangements required for morphogenesis. Several "noncore" AJ components have been identified, which modulate AJs to promote this plasticity but are not absolutely required for cell-cell adhesion.RESULTS: We previously identified dASPP as a positive regulator of dCsk (Drosophila C-terminal Src kinase). Here we show that dRASSF8, the Drosophila RASSF8 homolog, binds to dASPP and that this interaction is required for normal dASPP levels. Our genetic and biochemical data suggest that dRASSF8 acts in concert with dASPP to promote dCsk activity. Both proteins specifically localize to AJs and are mutually required for each other's localization. Furthermore, we observed abnormal E-cadherin localization in mutant pupal retinas, correlating with aberrant cellular arrangements. Loss of dCsk or overexpression of Src elicited similar AJ defects.CONCLUSIONS: Because Src is known to regulate AJs in both Drosophila and mammals, we propose that dASPP and dRASSF8 fine tune cell-cell adhesion during development by directing dCsk and Src activity. We show that the dASPP-dRASSF8 interaction is conserved in humans, suggesting that mammalian ASPP1/2 and RASSF8, which are candidate tumor-suppressor genes, restrict the activity of the Src proto-oncogene.
AB - BACKGROUND: Adherens junctions (AJs) provide structure to epithelial tissues by connecting adjacent cells through homophilic E-cadherin interactions and are linked to the actin cytoskeleton via the intermediate binding proteins beta-catenin and alpha-catenin. Rather than being static structures, AJs are extensively remodeled during development, allowing the cell rearrangements required for morphogenesis. Several "noncore" AJ components have been identified, which modulate AJs to promote this plasticity but are not absolutely required for cell-cell adhesion.RESULTS: We previously identified dASPP as a positive regulator of dCsk (Drosophila C-terminal Src kinase). Here we show that dRASSF8, the Drosophila RASSF8 homolog, binds to dASPP and that this interaction is required for normal dASPP levels. Our genetic and biochemical data suggest that dRASSF8 acts in concert with dASPP to promote dCsk activity. Both proteins specifically localize to AJs and are mutually required for each other's localization. Furthermore, we observed abnormal E-cadherin localization in mutant pupal retinas, correlating with aberrant cellular arrangements. Loss of dCsk or overexpression of Src elicited similar AJ defects.CONCLUSIONS: Because Src is known to regulate AJs in both Drosophila and mammals, we propose that dASPP and dRASSF8 fine tune cell-cell adhesion during development by directing dCsk and Src activity. We show that the dASPP-dRASSF8 interaction is conserved in humans, suggesting that mammalian ASPP1/2 and RASSF8, which are candidate tumor-suppressor genes, restrict the activity of the Src proto-oncogene.
KW - Adaptor Proteins, Signal Transducing/genetics
KW - Animals
KW - Apoptosis Regulatory Proteins/genetics
KW - Carrier Proteins/genetics
KW - Cell Adhesion/physiology
KW - Cell Line
KW - Drosophila/embryology
KW - Drosophila Proteins/genetics
KW - Gene Expression Regulation, Developmental/physiology
KW - Protein Binding
KW - Retina/embryology
KW - Tumor Suppressor Proteins/genetics
KW - Wings, Animal
U2 - 10.1016/j.cub.2009.10.027
DO - 10.1016/j.cub.2009.10.027
M3 - Journal article
C2 - 19931458
SN - 0960-9822
VL - 19
SP - 1969
EP - 1978
JO - Current biology : CB
JF - Current biology : CB
IS - 23
ER -